Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05906784 · ClinicalTrials.gov registry record · NA

Group-based Integrative Pain Management (IPMP+ Pilot)

A NA study of Chronic Pain, sponsored by University of California, San Francisco.

Completed
Registry status
NA
Development phase
44
Enrollment target
1
Study location

NCT05906784 is a NA study of Chronic Pain that has completed, run by University of California, San Francisco. The registered enrollment target is 44 participants, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05906784, a NA study of Chronic Pain, has completed, sponsored by University of California, San Francisco.

COMPLETED
Registry status
NA
Development phase
44 participants
Enrollment target
1
Study location

Study Summary

Socioeconomically disadvantaged populations have a high prevalence of chronic pain, exacerbated by social isolation, intersectional stigma, and disparities in pain assessment and treatment options. Effective interventions using a multilevel, biopsychosocial approach are needed to decrease the unequal burden of pain. The proposed pilot study will test group-based integrative models of pain management in primary care safety net clinics to improve pain care for racially and ethnically diverse low-income patients.

Conditions Studied

Interventions

  • OTHER Integrative Group Medical Visits
  • OTHER group acupuncture

Study Locations (1)

California

  • Tom Waddell Urban Health Clinic - San Francisco

Trial Details

FieldValue
Enrollment Target 44 participants
Start Date 2023-04-28
Est. Completion 2023-12-04
Phase NA

What the Registry Record Tells You About NCT05906784

The ClinicalTrials.gov registry entry for NCT05906784 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (94% lower). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Chronic Pain appearing as the primary indexed condition, and to 2 interventions - of which Integrative Group Medical Visits is the first listed.

NCT05906784 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT05906784 about?

NCT05906784 is a clinical study titled "Group-based Integrative Pain Management (IPMP+ Pilot)". Socioeconomically disadvantaged populations have a high prevalence of chronic pain, exacerbated by social isolation, intersectional stigma, and disparities in pain assessment and treatment options. Effective interventions using a multilevel, biopsychosocial approach are needed to decrease the unequa...

What is the current status of trial NCT05906784?

This trial is currently completed. It is a NA study. The enrollment target is 44 participants. The study started on 2023-04-28. Estimated completion is 2023-12-04.

What conditions does trial NCT05906784 study?

This clinical trial studies the following conditions: Chronic Pain.

What interventions are being tested in trial NCT05906784?

The interventions under investigation include: Integrative Group Medical Visits (OTHER), group acupuncture (OTHER).

Who is sponsoring clinical trial NCT05906784?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05906784 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.